Anti-HER3 antibodies and uses thereof

US9611331B2 · kind B2 · utility

Assignee

• Roche Glycart AG · CH

Inventors

• Birgit Bossenmaier · Hanerau-Hademarschen, DE
• Nikolaos Dimoudis · Wielenbach, DE
• Thomas Friess · Planegg, DE
• Guy Georges · Habach, DE
• Irene Kolm · Penzberg, DE
• Hans-Willi Krell · Penzberg, DE
• Valeria Lifke · Penzberg, DE
• Ekkehard Moessner · Kreuzlingen, CH

Key dates

• Filing date: Sep 8, 2014
• Grant date: Apr 4, 2017
• Expiry date: Sep 8, 2034

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/92
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to antibodies binding to human HER3 (anti-HER3 antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.